Intermediate arylamine compounds

US7026476B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim Pharmaceuticals, Inc. · US

Inventors

• Pier Francesco Cirillo · Woodbury, US
• Steffen Breitfelder · Aßmannshardt, DE
• Usha R. Patel · Brookfield, US
• John Proudfoot · Newtown, US
• Alan David Swinamer · Bethel, US

Key dates

• Filing date: Apr 28, 2003
• Grant date: Apr 11, 2006
• Expiry date: Sep 23, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D495/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are novel aromatic compounds which are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are and pharmaceutical compositions containing, intermediate compounds and processes of making such compounds.